Pancreatic Adenosquamous Carcinoma

general

A carcinoma that arises from the pancreas showing both ductal and squamous differentiation. The squamous component should represent at least 30% of the malignant cellular infiltrate. The prognosis is usually worse than that of ductal adenocarcinoma.

64

Centers

138

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Pancreatic Adenosquamous Carcinoma(64)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
68.0
2
NCI Comprehensive
Active Research Program
68.0
3
NCI Comprehensive
Active Research Program
68.0
4
NCI Comprehensive
Active Research Program
68.0
5
NCI Comprehensive
Active Research Program
68.0
6
NCI Comprehensive
Active Research Program
68.0
7
NCI Clinical
Active Research Program
68.0
8
NCI Comprehensive
Active Research Program
68.0
9
Active Research Program
68.0
10
NCI Clinical
Active Research Program
68.0
11
NCI Comprehensive
Active Research Program
68.0
12
Active Research Program
68.0
13
Active Research Program
68.0
14
Active Research Program
68.0
15
Active Research Program
68.0
16
NCI Comprehensive
Active Research Program
59.6
17
NCI Comprehensive
Active Research Program
59.6
18
NCI Comprehensive
Active Research Program
59.6
19
NCI Comprehensive
Active Research Program
59.6
20
NCI Clinical
Active Research Program
59.6
21
NCI Comprehensive
Active Research Program
59.6
22
NCI Comprehensive
Active Research Program
59.6
23
Active Research Program
59.6
24
Active Research Program
59.6
25
NCI Comprehensive
Active Research Program
42.3
26
NCI Comprehensive
Active Research Program
42.3
27
NCI Comprehensive
Active Research Program
42.3
28
NCI Comprehensive
Active Research Program
42.3
29
NCI Comprehensive
Active Research Program
42.3
30
NCI Comprehensive
Active Research Program
42.3
31
NCI Comprehensive
Active Research Program
42.3
32
NCI Comprehensive
Active Research Program
42.3
33
NCI Comprehensive
Active Research Program
42.3
3442.3
35
NCI Comprehensive
Active Research Program
42.3
36
NCI Comprehensive
Active Research Program
42.3
37
NCI Comprehensive
Active Research Program
42.3
38
NCI Comprehensive
Active Research Program
42.3
39
NCI Clinical
Active Research Program
42.3
40
NCI Comprehensive
Active Research Program
42.3
41
NCI Comprehensive
Active Research Program
42.3
42
NCI Comprehensive
Active Research Program
42.3
43
NCI Comprehensive
Active Research Program
42.3
44
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
42.3
45
NCI Comprehensive
Active Research Program
42.3
46
NCI Clinical
Active Research Program
42.3
47
Active Research Program
42.3
48
NCI Comprehensive
Active Research Program
42.3
49
NCI Comprehensive
Active Research Program
42.3
50
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
42.3
51
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
42.3
52
Active Research Program
42.3
53
NCI Comprehensive
Active Research Program
42.3
54
Active Research Program
42.3
55
Active Research Program
42.3
56
Active Research Program
42.3
57
Active Research Program
42.3
58
Active Research Program
42.3
59
Active Research Program
42.3
6042.3
61
Active Research Program
42.3
62
Active Research Program
42.3
63
Active Research Program
42.3
64
BC CancerVancouver, BC
Active Research Program
42.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →